, Tracking Stock Market Picks
Enter Symbol:
Impax Laboratories, Inc. (IPXL) [hlAlert]

Sector Perform

Impax Laboratories, Inc. (IPXL) rated Sector Perform with price target $25 by RBC Capital Mkts

Posted on: Wednesday,  Jun 15, 2011  9:25 AM ET by RBC Capital Mkts

RBC Capital Mkts rated Sector Perform Impax Laboratories, Inc. (NASDAQ: IPXL) on 06/15/2011. Previously RBC Capital Mkts rated Outperform Impax Laboratories, Inc. (NASDAQ:
IPXL) on 03/15/2011., when the stock price was $24.18. Since then, Impax Laboratories, Inc. has gained 10.42% as of 05/31/2011's recent price of $26.70.
If you would have followed the previous RBC Capital Mkts's recommendation on IPXL, you would have gained 10.42% of your investment in 77 days.

Impax Laboratories, Inc. is a technology-based, specialty pharmaceutical company. The Company is focused on the development and commercialization of bioequivalent and brand-name pharmaceuticals, utilizing its controlled-release and other in-house development and formulation expertise. In the generic pharmaceuticals market, the Company focuses its efforts on controlled-release generic versions of selected brand-name pharmaceuticals covering a range of therapeutic areas. In the brand-name pharmaceuticals market, Impax is developing products for the treatment of central nervous system (CNS), disorders. Its brand-name product portfolio consists of development-stage projects to which it is applying its formulation and development expertise to develop differentiated, modified, or controlled-release versions of marketed drug substances. The Company operates in two segments: Global Pharmaceuticals Division (Global Division) and the Impax Pharmaceutical Division (Impax Division).

RBC Capital Markets is an international corporate and investment bank that provides innovative solutions and a focused set of products and services to institutions, corporations, governments and high net worth clients around the world. With nearly 3,700 professional and support staff, we operate out of 75 offices in 15 countries and deliver our products and services through operations in Asia and Australasia, the UK and Europe and in every major North American city.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/15/2011 9:25 AM Hold
20.61 25.00
as of 12/30/2011
1 Week   
1 Month   
3 Months   
1 YTD up  10.42 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/31/2011 10:25 AM Hold
26.70 28.00
3/15/2011 10:25 AM Buy
24.18 28.00
1/7/2011 9:25 AM Buy
20.93 26.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy